Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-10463

Single-particle
3.2 Å
EMD-10463 Deposition: 07/11/2019
Map released: 26/08/2020
Last modified: 01/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-10463

Leishmania tarentolae proteasome 20S subunit complexed with LXE408 and bortezomib

EMD-10463

Single-particle
3.2 Å
EMD-10463 Deposition: 07/11/2019
Map released: 26/08/2020
Last modified: 01/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Leishmania donovani
Sample: Leishmania tarentolae proteasome 20S subunit complexed with LXE408 and bortezomib
Fitted models: 6td5

Deposition Authors: Srinivas H
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
PUBMED: 32667203
DOI: doi:10.1021/acs.jmedchem.0c00499
ISSN: 0022-2623
ASTM: JMCMAR